Bausch & Lomb (BLCO) Total Current Liabilities (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Total Current Liabilities came in at $1.9 billion in Q2 2026, up 2.72% on a YoY basis from $1.8 billion in Q2 2025, and up 3.85% quarter-over-quarter from $1.8 billion in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Total Current Liabilities (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Total Current Liabilities for 6 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities rose 2.72% year-over-year to $1.9 billion; the trailing twelve-month figure through Jun 2026 stood at $1.9 billion (up 2.72% YoY), and the FY2025 full-year result was $1.9 billion, up 10.47% from the prior year.
- Total Current Liabilities advanced to $1.9 billion in Q2 2026 per BLCO's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.9 billion in Q4 2025 and bottomed at $1.1 billion in Q1 2022.
- Historically, Total Current Liabilities has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2024.
- The sharpest annual moves came in 2024 and 2026: Total Current Liabilities increased 29.94% in 2024, then increased 2.72% in 2026.
- Over 5 years, Total Current Liabilities stood at $1.3 billion in 2022, then grew by 21.84% to $1.6 billion in 2023, then rose by 10.07% to $1.7 billion in 2024, then rose by 10.47% to $1.9 billion in 2025, then slipped by 1.56% to $1.9 billion in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.9 billion, $1.8 billion, and $1.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 1.89 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.89 Bn |
| Mar 31, 2026 | 1.82 Bn |
| Dec 31, 2025 | 1.92 Bn |
| Sep 30, 2025 | 1.90 Bn |
| Jun 30, 2025 | 1.84 Bn |
| Mar 31, 2025 | 1.73 Bn |
| Dec 31, 2024 | 1.74 Bn |
| Sep 30, 2024 | 1.80 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | 1.62 Bn |
| Dec 31, 2023 | 1.58 Bn |
| Sep 30, 2023 | 1.39 Bn |
| Jun 30, 2023 | 1.33 Bn |
| Mar 31, 2023 | 1.25 Bn |
| Dec 31, 2022 | 1.30 Bn |
| Sep 30, 2022 | 1.20 Bn |
| Jun 30, 2022 | 1.27 Bn |
| Mar 31, 2022 | 1.09 Bn |
| Dec 31, 2021 | 1.10 Bn |